MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42

被引:173
作者
Chou, Jinjiang [1 ,2 ]
Wang, Bingyu [1 ,2 ]
Zheng, Tianjing [1 ,2 ]
Li, Xiaoman [2 ,3 ]
Zheng, Lufeng [1 ,2 ]
Hu, Jinhang [1 ,2 ]
Zhang, Yan [1 ,2 ]
Xing, Yingying [1 ,2 ]
Xi, Tao [1 ,2 ]
机构
[1] China Pharmaceut Univ, Sch Life Sci & Technol, 24 Tongjiaxiang, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, 24 Tongjiaxiang, Nanjing 210009, Peoples R China
[3] Nanjing Univ Chinese Med, Jingsu Key Lab Pharmacol & Safety Evaluat Chinese, Sch Pharm, Nanjing 210023, Jiangsu, Peoples R China
关键词
MALAT1; miR-1; cdc42; ceRNA; Migration; Invasion; NONCODING RNA MALAT1; METASTASIS; EXPRESSION; PROMOTES; PROLIFERATION; ALPHA;
D O I
10.1016/j.bbrc.2016.02.102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Competitive endogenous messenger RNAs (ceRNAs) affect other RNAs transcription through competitively binding common microRNAs (miRNAs). In this study we identified long non-coding RNA (lncRNA) MALAT1 can function as a ceRNA of cell division cycle 42 (cdc42) 3'UTR in inducing migration and invasion of breast cancer cells via miR-1. We found that miR-1 bound both MALAT1 and cdc42 3'UTR directly. Further study showed that MALAT1 induced migration and invasion of breast cancer cells while reduced the level of cdc42. Our results suggest that MALAT1 regulated migration and invasion of breast cancer cells via affecting cdc42 through binding miR-1 competitively. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:262 / 269
页数:8
相关论文
共 23 条
  • [1] The relevance of EMT in breast cancer metastasis: Correlation or causality?
    Bill, Ruben
    Christofori, Gerhard
    [J]. FEBS LETTERS, 2015, 589 (14): : 1577 - 1587
  • [2] Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma
    Chen, Xiaoyue
    Yan, Qin
    Li, Shuangdi
    Zhou, Long
    Yang, Huajing
    Yang, Yixia
    Liu, Xuelian
    Wan, Xiaoping
    [J]. CANCER LETTERS, 2012, 314 (01) : 41 - 53
  • [3] Long noncoding RNAs: Novel insights into gastric cancer
    Fang, Xin-yu
    Pan, Hai-feng
    Leng, Rui-xue
    Ye, Dong-qing
    [J]. CANCER LETTERS, 2015, 356 (02) : 357 - 366
  • [4] The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
    Gutschner, Tony
    Haemmerle, Monika
    Eissmann, Moritz
    Hsu, Jeff
    Kim, Youngsoo
    Hung, Gene
    Revenko, Alexey
    Arun, Gayatri
    Stentrup, Marion
    Gross, Matthias
    Zoernig, Martin
    MacLeod, A. Robert
    Spector, David L.
    Diederichs, Sven
    [J]. CANCER RESEARCH, 2013, 73 (03) : 1180 - 1189
  • [5] ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up
    Halon, Agnieszka
    Donizy, Piotr
    Surowiak, Pawel
    Matkowski, Rafal
    [J]. CELLULAR ONCOLOGY, 2013, 36 (03) : 181 - 190
  • [6] Hallmarks of Cancer: The Next Generation
    Hanahan, Douglas
    Weinberg, Robert A.
    [J]. CELL, 2011, 144 (05) : 646 - 674
  • [7] Ji B., 2015, EBIOMEDICINE, V2, P794
  • [8] The functional significance of miR-1 and miR-133a in renal cell carcinoma
    Kawakami, Kazumori
    Enokida, Hideki
    Chiyomaru, Takeshi
    Tatarano, Shuichi
    Yoshino, Hirofumi
    Kagara, Ichiro
    Gotanda, Takenari
    Tachiwada, Tokushi
    Nishiyama, Kenryu
    Nohata, Nijiro
    Seki, Naohiko
    Nakagawa, Masayuki
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 (06) : 827 - 836
  • [9] Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer
    Kojima, S.
    Chiyomaru, T.
    Kawakami, K.
    Yoshino, H.
    Enokida, H.
    Nohata, N.
    Fuse, M.
    Ichikawa, T.
    Naya, Y.
    Nakagawa, M.
    Seki, N.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (02) : 405 - 413
  • [10] Breast cancer stem cells, EMT and therapeutic targets
    Kotiyal, Srishti
    Bhattacharya, Susinjan
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 453 (01) : 112 - 116